Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Photobiomodulation therapy for peripheral neuropathy in diabetic and cancer patients: A narrative review

PBMT represents a promising non-invasive therapeutic strategy for peripheral neuropathy management in diabetic individuals and cancer patients.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This narrative review examined photobiomodulation therapy for peripheral neuropathy in people with diabetes and in cancer patients receiving chemotherapy. The authors report that current evidence suggests it may reduce neuropathic pain, improve nerve conduction and quality of life, but they note that larger randomized trials are needed to standardize protocols and clarify long-term outcomes.

Who or what was studied
Patients with diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy
Limits stated in the abstract
The abstract describes a narrative review and states that further large-scale randomized clinical trials are required to standardize protocols and clarify long-term outcomes.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Peripheral neuropathy is a common and debilitating complication frequently observed in diabetic patients and individuals undergoing chemotherapy and radiotherapy for cancer treatment. Diabetic peripheral neuropathy (DPN) and chemotherapy-induced peripheral neuropathy (CIPN) significantly impair quality of life and may adversely affect oral health and daily functioning.

Objective

This narrative review aimed to evaluate the potential therapeutic effects of photobiomodulation therapy (PBMT) in the management of peripheral neuropathy, with particular focus on DPN and CIPN in cancer patients.

Methods

A literature search was conducted using PubMed, Scopus, and Google Scholar databases for studies published between 2010 and 2025. Relevant English-language studies investigating PBMT in peripheral neuropathy, neuropathic pain, nerve regeneration, biomarkers, and quality of life outcomes were included.

Results

Current evidence suggests that PBMT may reduce neuropathic pain, improve nerve conduction, enhance sensory function, and improve quality of life in patients with DPN and CIPN. PBMT has also demonstrated beneficial effects on neurobiological biomarkers, including calcitonin gene-related peptide and neuron-specific enolase. In addition, its anti-inflammatory and mitochondrial regulatory effects may contribute to nerve regeneration and tissue repair.

Conclusion

PBMT represents a promising non-invasive therapeutic strategy for peripheral neuropathy management in diabetic individuals and cancer patients. Although available evidence supports its safety and clinical efficacy, further large-scale randomized clinical trials are required to standardize treatment protocols and clarify long-term outcomes.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation therapy, Neuropathy, Photobiomodulation. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies